ArticlePloS one2021

Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors.

Keller J Toral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.